Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Liposomal Bupivacaine Versus Ropivacaine With Perineural Dexamethasone or Dexmedetomidine as Adjuncts for Adductor Canal Block Combined With IPACK Block in Total Knee Arthroplasty [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating liposomal bupivacaine versus ropivacaine, combined with either perineural dexamethasone or dexmedetomidine, for adductor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone (perineural) (dexamethasone)
  • Dexmedetomidine (Dexmedetomidine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Total Knee Anthroplasty, Nerve Block | NA | Status: RECRUITING